Review
Published on 03 Feb 2026
The impact of obesity-related systemic inflammation on the efficacy, toxicity, and biomarkers of immune checkpoint inhibitors in lung cancer: from mechanisms to clinical management
in I<mark class="highlighted">nflammation</mark>
Frontiers in Immunology
doi 10.3389/fimmu.2026.1757711
- 519 views
